An enlarged prostate, clinically known as benign prostatic hyperplasia (BPH), is a well-established risk factor for erectile dysfunction. Multiple large-scale studies have confirmed a consistent and strong relationship between the urinary symptoms BPH causes and both erectile and ejaculatory problems in men. The connection runs deeper than coincidence or shared aging, though. Researchers have identified several biological pathways that tie these two conditions together, and some of the medications used to treat BPH can independently worsen erections.
How Strong Is the Link
The epidemiological evidence connecting BPH and erectile dysfunction is substantial. Community-based studies across different geographic regions have repeatedly found that men with moderate-to-severe lower urinary tract symptoms (the hallmark complaints of BPH, like weak stream, frequent urination, and nighttime bathroom trips) face a significantly higher risk of erectile dysfunction, ejaculatory problems, and reduced sexual desire compared to men without those symptoms.1PubMed. Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) This association holds even after researchers control for age, meaning BPH-related symptoms appear to contribute to erectile problems on their own, not just because older men tend to have both.2PubMed Central. Pathogenic mechanisms linking benign prostatic hyperplasia, lower urinary tract symptoms and erectile dysfunction
One study looking specifically at prostate size found a strong negative correlation between prostate volume and erectile function scores. As the prostate grew larger, erectile dysfunction severity worsened in a graded, dose-response fashion.3PubMed Central. The Correlation Between Prostate Volume in Patients with Benign Prostatic Hyperplasia in Relation to Erectile Dysfunction That said, the relationship is more nuanced than “bigger prostate, worse erections,” as we’ll see shortly.
Why BPH and Erectile Dysfunction Share Biological Roots
The fact that these conditions travel together so reliably prompted researchers to look for shared biological explanations. Four main theories have emerged, each with varying degrees of supporting evidence.4PubMed. Erectile dysfunction and lower urinary tract symptoms secondary to BPH
The most well-studied involves nitric oxide, a molecule your body uses to relax smooth muscle throughout the pelvic region. In a healthy erection, nitric oxide signals blood vessels and erectile tissue to relax and fill with blood. The prostate and bladder outlet also rely on nitric oxide signaling to function smoothly. When this pathway becomes impaired, the effects show up in both places: the prostate region tightens and resists urine flow, while the penis struggles to engorge properly. This shared pathway is so central that drugs originally designed for erectile dysfunction (the same class as tadalafil and sildenafil) have been shown to improve urinary symptoms too.5PubMed. The nitric oxide pathway in the human prostate: clinical implications in men with lower urinary tract symptoms
A second pathway involves reduced blood supply. As men age, conditions like high blood pressure, diabetes, and atherosclerosis damage blood vessels throughout the body. The prostate and the penis are both downstream of the same arterial supply, and when that supply deteriorates, both organs can suffer chronic low-grade oxygen deprivation. Research has demonstrated that this vascular damage is an important contributing factor in the development of both BPH and erectile dysfunction.6PubMed. Vascular damage as a risk factor for benign prostatic hyperplasia and erectile dysfunction
A third mechanism involves Rho-kinase, an enzyme that promotes muscle contraction. When Rho-kinase activity is elevated, smooth muscle in the prostate, bladder neck, and penile tissue stays overly contracted. In the prostate, this contributes to urinary obstruction; in the penis, it prevents the relaxation needed for an erection.7PubMed. RhoA/Rho-kinase as a therapeutic target for the male urogenital tract The fourth proposed mechanism, autonomic nervous system hyperactivity (where the “fight or flight” nervous system stays in overdrive), has less supporting evidence. At least one study found that while autonomic activity was slightly elevated, it was not a fundamental driver of the BPH-ED link.8Turkish Journal of Medical Sciences. The relationship between lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: the role of autonomic hyperactivity
Emerging research also points to metabolic syndrome and chronic inflammation as key shared factors. Obesity-driven inflammatory processes can disrupt hormone production and damage prostate tissue simultaneously, which helps explain why men with metabolic syndrome have higher rates of both BPH and sexual dysfunction.9PubMed. Obesity and metabolic syndrome associated with systemic inflammation and the impact on the male reproductive system
Symptoms Matter More Than Prostate Size Alone
Here’s where the picture gets interesting. While one study found a clear relationship between prostate volume and erectile function, a larger body of clinical evidence suggests that urinary symptoms are actually a better predictor of erectile problems than the physical size of the gland. A study of men with BPH found that nearly all parameters of urinary symptom severity, including age, residual urine volume, urine flow rate, and nighttime frequency, correlated significantly with erectile function scores, but prostate volume itself did not reach significance.10The Journal of Sexual Medicine. Correlation Between Lower Urinary Tract Symptoms (LUTS) and Sexual Function in Benign Prostatic Hyperplasia: Impact of Treatment of LUTS on Sexual Function
This distinction matters for you practically. Two men can have the same prostate size on an ultrasound, but if one has barely any symptoms and the other is getting up four times a night, the symptomatic man is far more likely to also be struggling with erections. It also means that effectively treating the urinary symptoms, regardless of whether the prostate actually shrinks, may help with sexual function too.
How Nighttime Bathroom Trips Disrupt Erections
One of the more specific pathways researchers have identified involves nocturia, the medical term for waking up multiple times at night to urinate. This is one of the most bothersome BPH symptoms for men, and it turns out to have a direct connection to erectile health that goes beyond general annoyance.
During healthy sleep, men experience sleep-related erections (sometimes called nocturnal erections) several times per night, typically during REM sleep phases. These erections are not just incidental; they play a role in maintaining penile tissue health by oxygenating erectile tissue. When BPH-related bladder problems cause repeated nighttime awakenings, sleep architecture is fragmented, and the total duration of these erections drops. Research in men with prostate obstruction found that this sleep fragmentation from nocturia reduced the frequency and duration of sleep-related erections, which correlated with poorer overall erectile function.11PubMed Central. Association between Nocturnal Frequency and Erectile Function in Eugonadal Men with Benign Prostatic Obstruction: A Cross Sectional Study In other words, the constant sleep disruption from BPH may be quietly degrading erectile function over time, independent of the other biological pathways.
When BPH Medications Cause the Problem
This is where things get frustrating for many men. Some of the most commonly prescribed BPH medications can themselves cause or worsen erectile dysfunction, creating a situation where the treatment for one condition directly aggravates another.
5-Alpha Reductase Inhibitors
Drugs like finasteride and dutasteride work by blocking the conversion of testosterone into a more potent form called DHT, which drives prostate growth. They are effective at shrinking the prostate over time, but they interfere with hormonal signaling that the rest of the body also depends on. Sexual side effects, including reduced libido and erectile dysfunction, are well-documented. A systematic review comparing the herbal supplement saw palmetto to finasteride found that erectile dysfunction occurred in about 5% of men taking finasteride versus roughly 1% on saw palmetto.12JAMA. Saw Palmetto Extracts for Treatment of Benign Prostatic Hyperplasia: A Systematic Review
What concerns researchers more is the growing evidence that these sexual side effects can sometimes persist even after stopping the drug. Animal studies have shown that prolonged suppression of DHT leads to structural changes in penile smooth muscle, including fibrosis, that may become irreversible once a critical treatment duration is exceeded.13PubMed Central. Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment There is also increasing evidence that these drugs cross into the brain and may affect neurosteroid production, potentially contributing to a broader set of sexual and neurological symptoms that some men report after discontinuation.14International Journal of Impotence Research. The post-finasteride syndrome: possible etiological mechanisms and symptoms The clinical significance and prevalence of persistent post-drug symptoms in humans remains debated, but the possibility is worth discussing with a doctor before starting long-term therapy.
Alpha-Blockers
The other main class of BPH drugs, alpha-blockers like tamsulosin, alfuzosin, and doxazosin, relax smooth muscle in the prostate and bladder neck to improve urine flow. Their effects on erections are inconsistent across studies, with some men reporting improvements and others reporting worsened function. The more common sexual complaint with alpha-blockers is ejaculatory dysfunction, particularly with tamsulosin, though the differences between specific drugs in this class are not dramatic.15PubMed. Effects of alpha(1)-adrenoceptor antagonists on male sexual function For men whose primary concern is maintaining erectile function, alpha-blockers are generally considered a safer bet than 5-alpha reductase inhibitors, though ejaculatory changes are a real trade-off.
Treating Both Problems With One Pill
The recognition that BPH and erectile dysfunction share underlying pathways led to one of the more practical treatment developments in recent years. Tadalafil, widely known as a once-daily erectile dysfunction medication, received regulatory approval for treating BPH-related urinary symptoms in men with or without coexisting erectile dysfunction.16PubMed Central. A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction It works by boosting the nitric oxide signaling pathway discussed earlier, relaxing smooth muscle in both the prostate region and the penis.
The appeal is straightforward: instead of taking one drug for urinary symptoms that might worsen erections, and another drug to counteract that side effect, tadalafil addresses both at once. Clinical evidence supports its safety and effectiveness for this dual role.17PubMed Central. The use of a single daily dose of tadalafil to treat signs and symptoms of benign prostatic hyperplasia and erectile dysfunction It does not shrink the prostate the way finasteride or dutasteride does, so it may not be the best choice for men with very large prostates who need size reduction to prevent complications. But for men whose main complaints are bothersome urinary symptoms and erectile difficulties, it fills a gap that older BPH drugs could not.
Surgery and Sexual Function
When medications fail or BPH progresses to the point of urinary retention or recurrent infections, surgical intervention enters the conversation. The standard procedure for decades has been transurethral resection of the prostate (TURP), which removes obstructing prostate tissue through the urethra. TURP is effective at relieving urinary obstruction, but it carries a significant risk of sexual side effects, particularly ejaculatory dysfunction (retrograde ejaculation, where semen flows backward into the bladder) and, to a lesser extent, erectile dysfunction.18PubMed Central. A state-of-art review on the preservation of sexual function among various minimally invasive surgical treatments for benign prostatic hyperplasia
There has been some debate about whether TURP-related erectile dysfunction results from the procedure itself or from other factors. One study found that capsular perforation during surgery, which was thought to be a risk factor, did not significantly correlate with erectile problems, suggesting the relationship may depend on the specific location and extent of any surgical damage rather than perforation alone.19PubMed Central. The Effect of Transurethral Resection of the Prostate on Erectile Function in Patients with Benign Prostatic Hyperplasia
The sexual side effects of TURP have been a major driver behind the development of newer, minimally invasive procedures. Techniques like the UroLift system, Rezūm water vapor therapy, and Aquablation have gained traction in part because they provide meaningful symptom relief while better preserving sexual function. A systematic review comparing these newer procedures to traditional surgery found that patients who underwent UroLift and Rezūm actually showed improvements in erectile and ejaculatory function, while other minimally invasive approaches at least preserved baseline function rather than worsening it.20PubMed Central. Minimizing Sexual Dysfunction in BPH Surgery For men who are sexually active and value preserving that function, these newer options are worth discussing with a urologist, keeping in mind that some have shorter track records than TURP.
Saw Palmetto and Pelvic Floor Exercise
Men looking for gentler interventions often ask about saw palmetto, a plant extract that has been used for decades as an over-the-counter remedy for BPH symptoms. A systematic review found that saw palmetto produced improvements in urinary symptoms and flow rates comparable to finasteride, while causing significantly fewer sexual side effects: erectile dysfunction occurred in roughly 1% of men on saw palmetto versus about 5% on finasteride.12JAMA. Saw Palmetto Extracts for Treatment of Benign Prostatic Hyperplasia: A Systematic Review That said, later studies have been less enthusiastic about saw palmetto’s actual effectiveness for urinary symptoms, so the picture is mixed. Its lower rate of sexual side effects remains a point in its favor for men with mild symptoms who want to try something before committing to prescription medication.
Pelvic floor exercises are another option gaining attention. A study of men recovering from prostate surgery found that a structured pelvic floor training program based on health behavior principles led to meaningful improvements in both urinary symptom scores and erectile function scores compared to standard care.21International Urology and Nephrology. Application effect of pelvic floor function exercise based on health belief model in patients with benign prostatic hyperplasia after electrocautery While this was a specific post-surgical population, pelvic floor strengthening is low-risk and has a plausible mechanism of benefit: stronger pelvic muscles improve blood trapping in the penis during erections and can help with urinary control. For men dealing with mild versions of both problems, it is a reasonable addition to whatever else they are doing.
The Psychological Layer
Something that biological research often underplays is the psychological toll of living with BPH symptoms. Getting up multiple times a night, worrying about finding a bathroom, dealing with urgency in social settings: these experiences create anxiety, erode confidence, and disrupt intimacy. Anxiety is one of the most potent triggers of erectile dysfunction on its own, and many men with BPH enter a cycle where urinary symptoms cause stress, stress impairs erections, and erectile failure causes more stress. This psychological dimension does not replace the biological mechanisms discussed above, but it stacks on top of them. A man whose nitric oxide signaling is already compromised by vascular disease and whose sleep is fragmented by nocturia is especially vulnerable to the additional hit from performance anxiety. Addressing this cycle sometimes requires more than urology: talking openly with a partner, working with a therapist experienced in sexual health, or simply recognizing that the problem has a medical basis and is not a personal failing can all help break the feedback loop.